Log on / register
Feedback | Support | My details

Pre-publication history

Plasma levels of soluble urokinase-type plasminogen activator receptor (suPAR) and early mortality risk among patients enrolling for antiretroviral treatment in South Africa

Stephen D Lawn email, Landon Myer email, Nonzwakazi Bangani email, Monica Vogt email and Robin Wood email

BMC Infectious Diseases 2007, 7:41doi:10.1186/1471-2334-7-41

Pre-publication versions of this article and reviewers' reports

Original submission - Version 1Manuscript16 Feb 2007
Reviewer's ReportGuido Silvestri08 Mar 2007
Reviewer's ReportLudo Lavreys08 Mar 2007
Resubmission - Version 2ManuscriptAuthors' comments23 Mar 2007
Reviewer's ReportGuido Silvestri19 Apr 2007
Reviewer's ReportLudo Lavreys19 Apr 2007
Resubmission - Version 3ManuscriptAuthors' comments17 May 2007
Resubmission - Version 4Manuscript17 May 2007
Accepted17 May 2007
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.